[Budget impact analysis of a blood saving program for urgent traumatological surgery]
- PMID: 17266885
- DOI: 10.1157/13096938
[Budget impact analysis of a blood saving program for urgent traumatological surgery]
Abstract
Background and objective: To assess the cost-effectiveness and the budget impact of a Blood Saving Program (BSP) in patients older than 65 undergoing perthrocanteric hip fracture surgery.
Patients and method: Two groups of patients with perthrocanteric fracture were included. Group 1: patients not receiving treatment for perisurgical anaemia or treated with oral iron; Group 2: patients included in a BSP (treatment with endovenous iron sucrose and alfa epoetin, plus restrictive transfusional criteria). Effectiveness issues were: transfusion rate and number of red blood cell units transfused, length of postoperative stay and infection rate. Treatment cost was calculated using drug and transfused red blood cell unit prizes in 2003. We calculated potential patient population according to 2003 data.
Results: 144 patients were included, 43 of which were in the BSP. Both groups were comparable in gender, age, preoperative length of stay, ASA and haemoglobin level at admission. Patients included in the BSP were less transfused and had less infections but postoperative stay was similar in both groups. The budget impact was 239,148 euros 95% [confidence interval (CI) 202,312-311,980] at group 1 and 311,980 euros [95% CI 275,288-348,672] at the BSP group. Including the whole potential population in the BSP (during one year 400 patients) would mean a cost increase of 72,832 euros, avoiding transfusion in 92 patients, infection in 70 patients, and saving 328 red blood cell units.
Conclusions: The cost increase due to endovenous iron sucrose and alfa-epoetin can be considered affordable for the hospital budget. BSP provides lower transfusion and infection rates and saves red blood cell units, compared to the standard procedure. Differences in postoperative stay should be analyzed in further larger and prospective studies including more patients.
Comment in
-
[Cost of blood transfusion in Spain].Med Clin (Barc). 2008 Jan 19;130(1):37-8; author reply 38-9. doi: 10.1157/13114547. Med Clin (Barc). 2008. PMID: 18221648 Spanish. No abstract available.
Similar articles
-
Blood conservation in the critically ill.Am J Health Syst Pharm. 2007 Aug 15;64(16 Suppl 11):S11-8. doi: 10.2146/ajhp070245. Am J Health Syst Pharm. 2007. PMID: 17687066
-
[Perioperative anaemia in geriatric patients with hip fracture].Farm Hosp. 2005 Jul-Aug;29(4):250-7. doi: 10.1016/s1130-6343(05)73673-4. Farm Hosp. 2005. PMID: 16268741 Spanish.
-
The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.Trials. 2013 Sep 9;14:288. doi: 10.1186/1745-6215-14-288. Trials. 2013. PMID: 24015990 Free PMC article. Clinical Trial.
-
Erythropoietic agents for anemia of critical illness.Am J Health Syst Pharm. 2008 Mar 15;65(6):540-6. doi: 10.2146/ajhp070225. Am J Health Syst Pharm. 2008. PMID: 18319499 Review.
-
Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.Oncologist. 2006 Jan;11(1):73-82. doi: 10.1634/theoncologist.11-1-73. Oncologist. 2006. PMID: 16401716 Review.
Cited by
-
Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project.BMC Musculoskelet Disord. 2012 Feb 21;13:27. doi: 10.1186/1471-2474-13-27. BMC Musculoskelet Disord. 2012. PMID: 22353604 Free PMC article. Clinical Trial.
-
Budget-impact analyses: a critical review of published studies.Pharmacoeconomics. 2009;27(10):807-27. doi: 10.2165/11313770-000000000-00000. Pharmacoeconomics. 2009. PMID: 19803537 Review.
-
[Preoperative anemia in orthopedic surgery: clinical impact, diagnostics and treatment].Orthopade. 2011 Nov;40(11):1018-20, 1023-5, 1027-8. doi: 10.1007/s00132-011-1789-3. Orthopade. 2011. PMID: 21922268 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical